Translational research conference 2016
1 March 2016
The
Sessions will include presentations and discussion on:
Day 1
- Genomic Therapies
- Activating internal ribosome entry site in Duchenne muscular dystrophy / dystrophin 5
- From pathogenesis to therapy in spinal muscular atrophy
- Targeting 3'end elements involved in mRNA processing is an efficient therapeutic strategy for FacioScapuloHumeral Dystrophy: a new gene silencing approach
- Next generation biomarkers
- Next generation in vivo imaging technologies in DMD -the BIOIMAGE-NMD programme
- MRI Biomarker Outcome Measures in Charcot-Marie-Tooth disease and Inclusion Body Myositis
- Integration of pharmacodynamic biomarkers into a drug regulatory pipeline: Vamorolone/VBP15 in DMD
- poster sessions Â
Day 2
- Big Data
- Innovative bioinformatics solutions to identify genetic defects
- Big data, large sequencing challenges, and the technology behind it
- Neurology and Neurodegeneration Genomics England Clinical Interpretation Partnership (Neuro-GeCIP)
- MRC Strategic plan
- ohn Newsom-Davis Lecture The congenital myasthenic syndromes: better treatments through an understanding of disease mechanisms'
For more information visit the .